Radium-223 Dichloride Safe Long-term for Prostate CA, Bone Mets Radium-223 Dichloride Safe Long-term for Prostate CA, Bone Mets

Radium-223 dichloride shows good long-term safety for treating men with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases, according to final results from the ALSYMPCA trial.Reuters Health Information
Source: Medscape Urology Headlines - Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news